CORMEDIX INC. Increase (Decrease) in Accrued Liabilities
CORMEDIX INC. (CRMD) reported Increase (Decrease) in Accrued Liabilities of $8.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- CORMEDIX INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $58.97M.
- CORMEDIX INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$50.62M, a 17436.30% decline year-over-year.
- CORMEDIX INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $52.28M, a 248.94% increase year-over-year.
- CORMEDIX INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $54.81M, a 485.36% increase year-over-year.
- CORMEDIX INC. increase (decrease) in accrued liabilities for fiscal 2025 was $100.77M, a 338.42% increase from fiscal 2024.
- CORMEDIX INC. increase (decrease) in accrued liabilities for fiscal 2024 was $22.98M, a 667.42% increase from fiscal 2023.
- CORMEDIX INC. increase (decrease) in accrued liabilities for fiscal 2023 was $3.00M, a 211.35% increase from fiscal 2022.
- CORMEDIX INC. increase (decrease) in accrued liabilities for fiscal 2022 was $961.96K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accrued Liabilities 59 month | Increase (Decrease) in Accrued Liabilities 62 month | Increase (Decrease) in Accrued Liabilities 65 month | Increase (Decrease) in Accrued Liabilities 68 month | Increase (Decrease) in Accrued Liabilities 71 month | Increase (Decrease) in Accrued Liabilities 74 month | Increase (Decrease) in Accrued Liabilities 74 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $58.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $8.35M 10-Q · filed 2026-08-13 | $60.63M derived: sum of 3 quarters · filed 2026-08-13 | $115.44M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||
| 2026-03-31 | -$50.62M 10-Q · filed 2026-05-14 | $1.66M derived: sum of 2 quarters · filed 2026-05-14 | $56.47M derived: sum of 3 quarters · filed 2026-05-14 | $49.86M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||
| 2025-12-31 | $52.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $107.09M derived: sum of 2 quarters · filed 2026-03-05 | $100.48M derived: sum of 3 quarters · filed 2026-08-13 | $100.77M 10-K · filed 2026-03-05 | |||||||||||
| 2025-09-30 | $54.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $48.20M derived: sum of 2 quarters · filed 2026-08-13 | $48.49M 10-Q · filed 2025-11-12 | $63.47M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||
| 2025-06-30 | -$6.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.32M 10-Q · filed 2026-08-13 | -$6.24M 10-Q · filed 2025-08-07 | $8.66M derived: sum of 3 quarters · filed 2026-08-13 | $18.03M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-03-31 | $292.00K 10-Q · filed 2026-05-14 | $331.44K 10-Q · filed 2025-05-06 | $15.27M derived: sum of 2 quarters · filed 2026-05-14 | $24.64M derived: sum of 3 quarters · filed 2026-05-14 | $25.69M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||
| 2024-12-31 | $14.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $24.35M derived: sum of 2 quarters · filed 2026-03-05 | $25.40M derived: sum of 3 quarters · filed 2026-03-05 | $22.98M 10-K · filed 2026-03-05 | $22.98M 10-K · filed 2025-03-25 | ||||||||||
| 2024-09-30 | $9.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $10.42M derived: sum of 2 quarters · filed 2025-11-12 | $8.00M 10-Q · filed 2025-11-12 | $9.83M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||
| 2024-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.36M 10-Q · filed 2025-08-07 | $469.40K derived: sum of 3 quarters · filed 2025-08-07 | $1.26M derived: sum of 4 quarters · filed 2025-08-07 | |||||||||||
| 2024-03-31 | -$2.42M 10-Q · filed 2025-05-06 | -$585.21K derived: sum of 2 quarters · filed 2025-05-06 | $209.27K derived: sum of 3 quarters · filed 2025-05-06 | $1.46M derived: sum of 4 quarters · filed 2025-05-06 | |||||||||||
| 2023-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $2.62M derived: sum of 2 quarters · filed 2025-03-25 | $3.88M derived: sum of 3 quarters · filed 2025-03-25 | $3.00M 10-K · filed 2025-03-25 | |||||||||||
| 2023-09-30 | $794.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $2.05M derived: sum of 2 quarters · filed 2024-10-30 | $1.16M 10-Q · filed 2024-10-30 | $1.97M derived: sum of 4 quarters · filed 2024-10-30 | |||||||||||
| 2023-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $370.10K 10-Q · filed 2024-08-14 | $1.18M derived: sum of 3 quarters · filed 2024-08-14 | ||||||||||||
| 2023-03-31 | -$884.87K 10-Q · filed 2024-05-09 | -$77.50K derived: sum of 2 quarters · filed 2024-05-09 | |||||||||||||
| 2022-12-31 | $807.38K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $961.96K 10-K · filed 2024-03-12 | |||||||||||||
| 2022-09-30 | $154.59K 10-Q · filed 2023-11-14 | ||||||||||||||
| 2020-06-30 | -$144.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$473.01K 10-Q · filed 2020-08-10 | $375.81K derived: sum of 3 quarters · filed 2020-08-10 | $895.44K derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||
| 2020-03-31 | -$328.49K 10-Q · filed 2020-05-11 | $520.33K derived: sum of 2 quarters · filed 2020-05-11 | $1.04M derived: sum of 3 quarters · filed 2020-05-11 | $1.61M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||
| 2019-12-31 | $848.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.37M derived: sum of 2 quarters · filed 2020-03-16 | $1.94M derived: sum of 3 quarters · filed 2020-08-10 | -$363.28K 10-K · filed 2020-03-16 | |||||||||||
| 2019-09-30 | $519.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.09M derived: sum of 2 quarters · filed 2020-08-10 | -$1.21M 10-Q · filed 2019-11-14 | -$5.70M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||
| 2019-06-30 | $570.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.73M 10-Q · filed 2020-08-10 | -$6.22M derived: sum of 3 quarters · filed 2020-08-10 | -$1.65M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||
| 2019-03-31 | -$2.30M 10-Q · filed 2020-05-11 | -$6.79M derived: sum of 2 quarters · filed 2020-05-11 | -$2.22M derived: sum of 3 quarters · filed 2020-05-11 | -$2.22M derived: sum of 4 quarters · filed 2020-05-11 | |||||||||||
| 2018-12-31 | -$4.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $86.09K derived: sum of 2 quarters · filed 2020-03-16 | $81.15K derived: sum of 3 quarters · filed 2020-03-16 | $997.72K 10-K · filed 2020-03-16 | |||||||||||
| 2018-09-30 | $4.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $4.56M derived: sum of 2 quarters · filed 2019-11-14 | $5.48M 10-Q · filed 2019-11-14 | $6.97M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||
| 2018-06-30 | -$4.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $911.64K 10-Q · filed 2019-08-14 | $2.40M derived: sum of 3 quarters · filed 2019-08-14 | $3.15M derived: sum of 4 quarters · filed 2019-08-14 | |||||||||||
| 2018-03-31 | $916.58K 10-Q · filed 2019-05-13 | $2.41M derived: sum of 2 quarters · filed 2019-05-29 | $3.15M derived: sum of 3 quarters · filed 2019-05-29 | $3.21M derived: sum of 4 quarters · filed 2019-05-29 | |||||||||||
| 2017-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-29 | $2.24M derived: sum of 2 quarters · filed 2019-05-29 | $2.29M derived: sum of 3 quarters · filed 2019-05-29 | $2.02M 10-K · filed 2019-05-29 | |||||||||||
| 2017-09-30 | $745.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $803.63K derived: sum of 2 quarters · filed 2018-11-14 | $533.34K 10-Q · filed 2018-11-14 | ||||||||||||
| 2017-06-30 | $58.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$212.06K 10-Q · filed 2018-08-14 | |||||||||||||
| 2017-03-31 | -$270.29K 10-Q · filed 2018-05-15 | ||||||||||||||
| 2016-09-30 | $1.92M 10-Q · filed 2017-11-09 | ||||||||||||||
| 2016-03-31 | $119.44K 10-Q · filed 2017-05-10 | ||||||||||||||
| 2012-09-30 | $415.62K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-03-27 | $414.51K derived: sum of 2 quarters · filed 2013-03-27 | $291.83K 10-Q/A · filed 2013-03-27 | -$33.17K 10-Q · filed 2012-11-13 | -$699.66K derived: sum of 4 quarters · filed 2013-03-27 | $588.35K 10-Q/A · filed 2013-03-27 | $263.35K 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | -$1.11K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-06 | -$123.79K 10-Q/A · filed 2012-09-06 | -$1.12M derived: sum of 3 quarters · filed 2012-09-06 | -$89.96K derived: sum of 4 quarters · filed 2013-03-27 | $172.72K 10-Q/A · filed 2012-09-06 | ||||||||||
| 2012-03-31 | -$122.68K 10-Q · filed 2012-05-15 | -$1.11M derived: sum of 2 quarters · filed 2012-05-15 | -$88.85K derived: sum of 3 quarters · filed 2013-03-27 | $24.49K derived: sum of 4 quarters · filed 2013-03-27 | $173.83K 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | -$991.49K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2012-04-26 | $33.83K derived: sum of 2 quarters · filed 2013-03-27 | $147.17K derived: sum of 3 quarters · filed 2013-03-27 | -$139.85K 10-K/A · filed 2012-04-26 | $296.51K 10-K/A · filed 2012-04-26 | ||||||||||
| 2011-09-30 | $1.03M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-03-27 | $1.14M derived: sum of 2 quarters · filed 2013-03-27 | $851.64K 10-Q/A · filed 2013-03-27 | $867.20K derived: sum of 4 quarters · filed 2013-03-27 | $1.29M 10-Q · filed 2011-11-10 | ||||||||||
| 2011-06-30 | $113.34K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-06 | -$173.68K 10-Q/A · filed 2012-09-06 | -$158.12K derived: sum of 3 quarters · filed 2012-09-06 | -$85.44K derived: sum of 4 quarters · filed 2012-09-06 | $262.69K 10-Q · filed 2011-08-09 | ||||||||||
| 2011-03-31 | -$287.03K 10-Q · filed 2012-05-15 | -$271.47K derived: sum of 2 quarters · filed 2012-05-15 | -$198.79K derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $15.56K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-04-26 | $88.24K derived: sum of 2 quarters · filed 2012-04-26 | $361.37K 10-K/A · filed 2012-04-26 | ||||||||||||
| 2010-09-30 | $72.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $345.81K 10-Q · filed 2011-11-10 | |||||||||||||
| 2010-06-30 | $273.13K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |